Asco Srl - Bari

Asco Srl - Bari company information, Employees & Contact Information

Explore related pages

Related company profiles:

ASCO was founded in November 1985 and, since then, its main purpose is to take care of the handling of national and international transport, by sea and by land, together with combined logistic services offering a global consulting service on these fields to its customers. Always at its clients complete disposal offering logistic assistance strictly connected to door-to-door delicate process, ASCO uses a computerized system which allows a 24 hours shipments monitoring so to have a detailed check of both transit and deliveries on real time. A qualified staff with a good knowledge of the main foreign languages is always at disposal of both Italian and foreign customers. ASCO group has diversified and amplified the range of its services; two travel agencies, I Viaggi di Salomone, are specialized in Business travel, creation and handling of tour packages and events organization. I Viaggi di Salomone affiliato Mascotur e I Viaggi di Salomone affiliato Mascotur Acquaviva ad Acquaviva delle Fonti, sono le agenzie di viaggio del gruppo ASCO. I Viaggi di Salomone affiliato Mascotur, agenzia creata nel 2001, che si trova presso l’Interporto Regionale della Puglia, ad oggi possiede un’ampia clientela a cui vengono forniti tutti i servizi di business e turismo. Dal 2002 forte del bagaglio esperienziale di un team motivato ed esperto è nato il progetto dell’area organizzazione eventi. A completamento dei servizi che offre ai propri clienti, I Viaggi di Salomone ha creato il Centro Servizi Mascotur Interporto, che consta di una Sala conferenze multimediale e un Servizio navetta. La stretta collaborazione con cui lavorano le diverse aree del gruppo, permette la creazione di accordi preferenziali con i fornitori. Accordi che assicurano un ampio margine di competitività sul mercato.

Company Details

Employees
15
Founded
-
Address
Via Traversa Maestri Del Lavoro,1, Bari,italy 70123,italy
Industry
Transportation, Logistics, Supply Chain And Storage
NAICS
Transportation and Warehousing
Support Activities for Transportation
Support Activities for Air Transportation
Support Activities for Rail Transportation
Support Activities for Water Transportation
Support Activities for Road Transportation
Freight Transportation Arrangement
Other Support Activities for Transportation
Airport Operations
Other Support Activities for Air Transportation
Port and Harbor Operations
Marine Cargo Handling
Navigational Services to Shipping
Other Support Activities for Water Transportation
Motor Vehicle Towing
Other Support Activities for Road Transportation
Air Traffic Control
Other Airport Operations
Packing and Crating
All Other Support Activities for Transportation
Website
asco.it
HQ
BARI, Italy
Looking for a particular Asco Srl - Bari employee's phone or email?

Asco Srl - Bari Questions

News

Cliff Hudis on how AI in cancer care is “inevitable”—and ASCO is working to make it safer - The Cancer Letter

Cliff Hudis on how AI in cancer care is “inevitable”—and ASCO is working to make it safer The Cancer Letter

No ASCO glory for Caribou | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline

No ASCO glory for Caribou | ApexOnco - Clinical Trials news and analysis Oncology Pipeline

Political, playful, absurdist: LA artists known as Asco - KCRW

Political, playful, absurdist: LA artists known as Asco KCRW

FDA, ASCO propose principles for proper dosing in cancer drug development - Regulatory Affairs Professionals Society | RAPS

FDA, ASCO propose principles for proper dosing in cancer drug development Regulatory Affairs Professionals Society | RAPS

ASCO 2025 For Trainees And Residents - Oncodaily

ASCO 2025 For Trainees And Residents Oncodaily

Game-Changers and Paradigm Shifts: ASCO 2025 Data Shake Up Breast Cancer Care - Oncology News Central

Game-Changers and Paradigm Shifts: ASCO 2025 Data Shake Up Breast Cancer Care Oncology News Central

ASCO 2025: what went down this week? - Labiotech.eu

ASCO 2025: what went down this week? Labiotech.eu

The Power of Choice in Cancer Care: Why It Matters - Medscape

The Power of Choice in Cancer Care: Why It Matters Medscape

‘Asco: Without Permission’ honors four East L.A. friends who changed Chicano art - Los Angeles Times

‘Asco: Without Permission’ honors four East L.A. friends who changed Chicano art Los Angeles Times

Breast Cancer Experts Bookmark Top Abstracts to Watch at the 2025 ASCO Annual Meeting - OncLive

Breast Cancer Experts Bookmark Top Abstracts to Watch at the 2025 ASCO Annual Meeting OncLive

How This Trailblazing Chicano Collective Rewrote the Art Canon - Artnet News

How This Trailblazing Chicano Collective Rewrote the Art Canon Artnet News

ctDNA Testing in CRC Management: Is It Ready for Prime Time? - ASCO Daily News

ctDNA Testing in CRC Management: Is It Ready for Prime Time? ASCO Daily News

TRITON3 Final Overall Survival Results for Rucaparib in BRCA-Mutated Prostate Cancer - Alan Bryce - UroToday

TRITON3 Final Overall Survival Results for Rucaparib in BRCA-Mutated Prostate Cancer - Alan Bryce UroToday

[ASCO 2025] ‘LEAP-015 trial failed, but it left valuable lesson’ - koreabiomed.com

[ASCO 2025] ‘LEAP-015 trial failed, but it left valuable lesson’ koreabiomed.com

ASCO 2025 for Trainees and Residents: Your Ultimate Guide to Success - Oncodaily

ASCO 2025 for Trainees and Residents: Your Ultimate Guide to Success Oncodaily

ON DEMAND: ASCO Direct™ 2025 Clinical Track Webinars – Highlights through an Australian lens - the limbic

ON DEMAND: ASCO Direct™ 2025 Clinical Track Webinars – Highlights through an Australian lens the limbic

ASCO-GU – Arcus goes it alone in HIF2α | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline

ASCO-GU – Arcus goes it alone in HIF2α | ApexOnco - Clinical Trials news and analysis Oncology Pipeline

ASCO: Cautious Big Pharmas double down on past wins—steering clear of radioligands and cell therapy - Fierce Biotech

ASCO: Cautious Big Pharmas double down on past wins—steering clear of radioligands and cell therapy Fierce Biotech

Olubukola Ayodeyele: It’s Day 1 of ASCO 2025 and the Session on Financial Toxicity Has Left Me Deeply Reflective - Oncodaily

Olubukola Ayodeyele: It’s Day 1 of ASCO 2025 and the Session on Financial Toxicity Has Left Me Deeply Reflective Oncodaily

ACS, ASCO combine online patient information services - The Cancer Letter

ACS, ASCO combine online patient information services The Cancer Letter

Ingrid Mayer: 2024 marks my third ASCO with AstraZeneca! - Oncodaily

Ingrid Mayer: 2024 marks my third ASCO with AstraZeneca! Oncodaily

“It’s Dire”: Unprecedented Oncologist Faculty Departures Prompt ASCO Response - Oncology News Central

“It’s Dire”: Unprecedented Oncologist Faculty Departures Prompt ASCO Response Oncology News Central

ASCO: Return to in-person 'zoo that it always was,' with added COVID challenges—and bad shoes - Fierce Biotech

ASCO: Return to in-person 'zoo that it always was,' with added COVID challenges—and bad shoes Fierce Biotech

Lung cancer dominates ASCO social media conversation among health care professionals - Healio

Lung cancer dominates ASCO social media conversation among health care professionals Healio

Dr. Jennifer A. Pietenpol Honored With the 2024 Science of Oncology Award for Groundbreaking Discoveries in Triple-Negative Breast Cancer - ASCO Daily News

Dr. Jennifer A. Pietenpol Honored With the 2024 Science of Oncology Award for Groundbreaking Discoveries in Triple-Negative Breast Cancer ASCO Daily News

ASCO: It's all tied up? Mirati's KRAS data are 'identical' to Amgen's, researcher says - Fierce Biotech

ASCO: It's all tied up? Mirati's KRAS data are 'identical' to Amgen's, researcher says Fierce Biotech

Mutation Matchmaking - UNM HSC Newsroom

Mutation Matchmaking UNM HSC Newsroom

After ASCO 2018: Sylvester Presenter Among ‘Cream of the Crop’ - University of Miami

After ASCO 2018: Sylvester Presenter Among ‘Cream of the Crop’ University of Miami

Zoe Betancourt: Though ASCO Advocacy Summit is over, it’s not too late to take part in ASCO’s Week of Action - Oncodaily

Zoe Betancourt: Though ASCO Advocacy Summit is over, it’s not too late to take part in ASCO’s Week of Action Oncodaily

These ’70s East L.A. Chicano artists are having a major revival — but infighting threatens their legacy - Los Angeles Times

These ’70s East L.A. Chicano artists are having a major revival — but infighting threatens their legacy Los Angeles Times

Transgene and NEC Present New Data on TG4050 at ASCO 2023: Press Releases - NEC Global

Transgene and NEC Present New Data on TG4050 at ASCO 2023: Press Releases NEC Global

Editor's Corner—When ASCO dueled with the world's biggest pop star, Swift Biotech was ready for it - Fierce Biotech

Editor's Corner—When ASCO dueled with the world's biggest pop star, Swift Biotech was ready for it Fierce Biotech

ASCO 2023 highlights innovation in drugs and exhibits - PharmaLive

ASCO 2023 highlights innovation in drugs and exhibits PharmaLive

Pamela Kunz: It’s been such a joy to be an ASCO volunteer - Oncodaily

Pamela Kunz: It’s been such a joy to be an ASCO volunteer Oncodaily

Fear of Cancer Recurrence or Progression: What Is It and What Can We Do About It? - ASCO Publications

Fear of Cancer Recurrence or Progression: What Is It and What Can We Do About It? ASCO Publications

Financial Toxicity Tumor Board: Can It Reduce Treatment Costs? - The ASCO Post

Financial Toxicity Tumor Board: Can It Reduce Treatment Costs? The ASCO Post

ASCO 2024 Interview: Luis E. Raez - European Medical Journal

ASCO 2024 Interview: Luis E. Raez European Medical Journal

Ashley Sumrall: It’s always energizing to be at ASCO HQ - Oncodaily

Ashley Sumrall: It’s always energizing to be at ASCO HQ Oncodaily

Dr. Arul Chinnaiyan Receives the 2021 Science of Oncology Award - ASCO Daily News

Dr. Arul Chinnaiyan Receives the 2021 Science of Oncology Award ASCO Daily News

ASCO24: AstraZeneca won cancer’s big meeting — again. Will that help it fulfill its $80 billion ambition? - statnews.com

ASCO24: AstraZeneca won cancer’s big meeting — again. Will that help it fulfill its $80 billion ambition? statnews.com

Schilsky Says Farewell as Retirement From ASCO Approaches - OncLive

Schilsky Says Farewell as Retirement From ASCO Approaches OncLive

What Is Clinical Utility in a Tumor Biomarker Test? Former ASCO President Knows It When He Sees It - The American Journal of Managed Care® (AJMC®)

What Is Clinical Utility in a Tumor Biomarker Test? Former ASCO President Knows It When He Sees It The American Journal of Managed Care® (AJMC®)

ASCO: ‘Any way you slice’ it, Arcellx's CAR-T is matching J&J-Legend’s Carvykti, analyst says - Fierce Biotech

ASCO: ‘Any way you slice’ it, Arcellx's CAR-T is matching J&J-Legend’s Carvykti, analyst says Fierce Biotech

Disease-Free Survival As a Clinical Trial Endpoint: Does It Matter, and to Whom? - ASCO Daily News

Disease-Free Survival As a Clinical Trial Endpoint: Does It Matter, and to Whom? ASCO Daily News

3 Intriguing Cancer Drugs With Data Coming at ASCO Next Month - Fox Business

3 Intriguing Cancer Drugs With Data Coming at ASCO Next Month Fox Business

Precision medicine: Opening the aperture - McKinsey & Company

Precision medicine: Opening the aperture McKinsey & Company

ASCO bus brings it all together - Vanuatu Daily Post

ASCO bus brings it all together Vanuatu Daily Post

Top Asco Srl - Bari Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant